Literature DB >> 10901739

Breast cancer prevention: a review of current evidence.

V G Vogel1.   

Abstract

The National Cancer Institute has created a breast cancer risk assessment tool that quickly estimates a woman's individualized absolute risk of developing breast cancer. Understanding the magnitude of risk is important because recent data show that breast cancer incidence may be reduced. All women may improve their overall health and thus perhaps minimize breast cancer risk by maintaining a healthy weight, avoiding cigarettes, limiting alcohol consumption, getting regular exercise, and avoiding non-diagnostic ionizing radiation. Nevertheless, no lifestyle modifications have yet been proven to prevent or definitively lower the risk of breast cancer. In addition, women whose personal breast cancer risk is high may consider reducing risk by pharmacologic or surgical means. In such women, a five-year course of tamoxifen reduced the risk of invasive breast cancer by 49%; women with lobular carcinoma in situ or atypical hyperplasia experienced even greater risk reductions. Because of the potential for vascular and endometrial side effects, women who are candidates for a preventive course of tamoxifen must be counseled regarding its relative risks and benefits. Prophylactic mastectomy offers at least a 90% reduction in the risk of breast cancer, but the physical and psychological changes involved in such a procedure make it a difficult choice for many women. Breast cancer risk assessment and appropriate counseling are becoming standard components of breast cancer screening and overall health maintenance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10901739     DOI: 10.3322/canjclin.50.3.156

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  7 in total

1.  Ability of Medicaid claims data to identify incident cases of breast cancer in the Ohio Medicaid population.

Authors:  Siran M Koroukian; Gregory S Cooper; Alfred A Rimm
Journal:  Health Serv Res       Date:  2003-06       Impact factor: 3.402

2.  Tamoxifen for breast cancer chemoprevention: low uptake by high-risk women after evaluation of a breast lump.

Authors:  Rebecca Taylor; Kenneth Taguchi
Journal:  Ann Fam Med       Date:  2005 May-Jun       Impact factor: 5.166

3.  Human oestrogenic 17beta-hydroxysteroid dehydrogenase specificity: enzyme regulation through an NADPH-dependent substrate inhibition towards the highly specific oestrone reduction.

Authors:  A Gangloff; A Garneau; Y W Huang; F Yang; S X Lin
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

Review 4.  Prophylactic interventions on children: balancing human rights with public health.

Authors:  F M Hodges; J S Svoboda; R S Van Howe
Journal:  J Med Ethics       Date:  2002-02       Impact factor: 2.903

5.  The Evaluation of p53 Polymorphism at Codon 72 and Association With Breast Cancer in Iran: A Systematic Review and Meta-analysis.

Authors:  Abozar Soleimani; Yousef Rahmani; Negin Farshchian; Ali Delpisheh; Kivan Khassi; Afshar Shahmohammadi; Nasrin Amirifard
Journal:  J Cancer Prev       Date:  2016-12-30

6.  Breast Cancer Knowledge, Attitudes and Practices amongst Women in Qatar.

Authors:  Ehab Hamed; Bayan Alemrayat; Mohamed Ahmed Syed; Suhad Daher-Nashif; Hadi Mohamad Abu Rasheed; Tanya Kane
Journal:  Int J Environ Res Public Health       Date:  2022-03-28       Impact factor: 3.390

7.  Weight, height, body mass index and risk of breast cancer in postmenopausal women: a case-control study.

Authors:  Ali Montazeri; Jila Sadighi; Faranak Farzadi; Farzaneh Maftoon; Mariam Vahdaninia; Mariam Ansari; Akram Sajadian; Mandana Ebrahimi; Shahpar Haghighat; Iraj Harirchi
Journal:  BMC Cancer       Date:  2008-09-30       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.